close

Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, and food testing laboratories. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. This segment serves hospital laboratories, reference laboratories, physician office laboratories, government agencies, and diagnostic manufacturers. The company was founded in 1952 and is headquartered in Hercules, California.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	103.10
Volume	78705
Volume Avg	73056
52 Week High	126.98
52 Week Low	84.02
PE	16.71
PE (group average)	57
EPS Year	6.26
EPS change Q/Q	-51.64%
EPS change Q/Q Yr ago	-7.09%
EPS change Q/Q next Q est	-7.81%
EPS change Y/Y	-17.7%
REV change Q/Q	-9.11%
REV change Q/Q Yr ago	6.8%
EPS next Q est	1.28
EPS next Y est	6.36
Divident Annual	0.00
Dividend Yield	0%